Clinisol Injection, Solution
Product Images NDC 0338-0502

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Clinisol (NDC 0338-0502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clinisol Representative Container Label Ndc 0338-0502-03 (Image 01)

Clinisol Representative Container Label Ndc 0338-0502-03 (Image 01)
This is a description of an Amino Acid injection packaged in a 500 mL Pharmacy Bulk Package with Lot EXP 2B6187 and NDC 0338-0502-03. It contains 15% Clinisol Amino Acid with Pharmacy Bulk Package for intravenous administration as directed by a physician. It has a balanced pH level adjusted with glacial acetic acid, and contains essential and non-essential amino acids. The solution is sterile, non-pyrogenic and has an osmolarity of 1367 mOsmol/l. The container is manufactured by Baxter and has a PL 146 plastic label. It's advisable not to use if the solution is not clear or if it has been penetrated for over four hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.